透视联合MRA融合图像引导在髂动脉腔内介入中的应用:随机对照试验研究方案
本研究为多中心随机对照试验,计划纳入106例有症状的髂总动脉和/或髂外动脉狭窄或闭塞、且6个月内接受过盆腔至下肢诊断性MRA、有腔内介入指征的患者。患者随机分为对照组(无3D图像融合引导)和研究组(有3D图像融合引导),主要终点为碘对比剂用量(mL)。
要点
- 3D图像融合将术前MRA叠加于透视屏幕,可随床和C臂移动。
- 主要终点为碘对比剂用量,次要终点包括技术成功、透视时间和辐射剂量。
- 技术成功定义为治疗病变残留狭窄<30%。
核心结论
- 本研究旨在评估3D图像融合技术在髂动脉介入中对碘对比剂用量的附加价值。
研究设计与样本
- 多中心随机对照试验,计划纳入106例>18岁有症状的髂总动脉和/或髂外动脉狭窄或闭塞患者。
- 患者需有6个月内盆腔至下肢诊断性MRA,且有腔内介入指征。
- 随机分为对照组(无3D融合引导)和研究组(有3D融合引导)。
关键数值与推荐
- 主要终点为碘对比剂用量(mL)。
- 次要终点包括技术成功(治疗病变残留狭窄<30%)、透视时间和辐射剂量(剂量面积乘积,mGycm2)。
临床怎么用
- 若证实有效,3D图像融合引导可能减少髂动脉介入中的碘对比剂用量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular iliac artery interventions rely on the use of two-dimensional digital subtraction angiographies with an iodinated contrast agent and ionizing radiation. The amount of iodinated contrast agent should be limited because of its potentially nephrotoxic effects. Three-dimensional (3D) image fusion requires registration of a preprocedural magnetic resonance angiogram (MRA) or computed tomography (CT) angiogram to a perprocedurally acquired cone-beam CT or two fluoroscopic orthogonal projections. After registration, the 3D angiography images can be overlaid on the fluoroscopy screen and will follow table and C-arm movements. This study will assess the added value of the 3D image fusion technique in iliac artery interventions regarding the amount of the iodinated contrast agent administered. METHODS/DESIGN: The study cohort will comprise 106 patients (> 18 years) with symptomatic common and/or external iliac artery stenoses or occlusions and a recent (< 6 months) diagnostic MRA from the pelvis through the lower extremities, for which an endovascular intervention is indicated. Patients will be randomized into the control or study group (i.e. treatment without or with 3D image fusion guidance). The primary endpoint is the amount of administered iodinated contrast agent (mL). Secondary outcomes are technical success of the procedure, defined as < 30% residual stenosis over the treated lesion, fluoroscopy time, and radiation dose as dose area product (mGycm2). Patient participation in the study will be completed after hospital discharge. DISCUSSION: This study is a randomized controlled multicenter trial to provide evidence on the effect of the 3D image fusion technique on the amount of administered iodinated contrast during endovascular common and/or external iliac artery interventions. TRIAL REGISTRATION: Nederlands Trial Register, NTR5008 . Registered on 16 December 2014.
引用
- Goudeketting SR, Heinen SGH, de Haan MW, et al. Fluoroscopy with MRA fusion image guidance in endovascular iliac artery interventions: study protocol for a randomized controlled trial (3DMR-Iliac-roadmapping study). Trials. 2018. PMID: 30382900. doi:10.1186/s13063-018-2981-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。